{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:37:58Z","timestamp":1792607878514,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mcpro.2025.101314","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:39:20Z","timestamp":1760827160000},"page":"101314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of Cathepsin L as the Molecular Target of Hydroxychloroquine With Chemical Proteomics"],"prefix":"10.1016","volume":"24","author":[{"given":"Jin","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-9454","authenticated-orcid":false,"given":"Bingjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-4369","authenticated-orcid":false,"given":"Karen Ka-Yan","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Kin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2244-6516","authenticated-orcid":false,"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2025.101314_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/jm990437l","article-title":"Structure\u2212 function relationships in aminoquinolines: effect of amino and chloro groups on quinoline\u2212 hematin complex formation, inhibition of \u03b2-hematin formation, and antiplasmodial activity","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcpro.2025.101314_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebiom.2017.09.034","article-title":"Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice","volume":"24","author":"Li","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mcpro.2025.101314_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/2159-8290.CD-18-0706","article-title":"PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer","volume":"9","author":"Rebecca","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mcpro.2025.101314_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/acscentsci.2c01325","article-title":"A turn-on fluorescent amino acid sensor reveals chloroquine\u2019s effect on cellular amino acids via inhibiting Cathepsin L","volume":"9","author":"Smith","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.mcpro.2025.101314_bib5","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mcpro.2025.101314_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mcpro.2025.101314_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mcpro.2025.101314_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101735","article-title":"Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: a narrative review","volume":"35","author":"Hashem","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.mcpro.2025.101314_bib9","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/j.1460-2075.1984.tb02195.x","article-title":"Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine","volume":"3","author":"Yayon","year":"1984","journal-title":"EMBO J."},{"key":"10.1016\/j.mcpro.2025.101314_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-7258(93)90056-J","article-title":"Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum","volume":"57","author":"Slater","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mcpro.2025.101314_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.mcpro.2025.101314_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101314_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41467-020-20457-w","article-title":"Host and viral determinants for efficient SARS-CoV-2 infection of the human lung","volume":"12","author":"Chu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.101314_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101314_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100759","article-title":"The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection","volume":"296","author":"Carlos","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.101314_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 is a host factor for SARS-CoV-2 infection","volume":"370","author":"Daly","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2025.101314_bib17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s42255-020-00324-0","article-title":"HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry","volume":"2","author":"Wei","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.mcpro.2025.101314_bib18","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1021\/acscentsci.0c01537","article-title":"CD209L\/L-SIGN and CD209\/DC-SIGN Act as receptors for SARS-CoV-2","volume":"7","author":"Amraei","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.mcpro.2025.101314_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","article-title":"AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.mcpro.2025.101314_bib20","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.cell.2023.06.005","article-title":"TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry","volume":"186","author":"Baggen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101314_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mcpro.2025.101314_bib22","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1038\/s41467-021-25729-7","article-title":"A CRISPR\/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses","volume":"12","author":"Beumer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.101314_bib23","doi-asserted-by":"crossref","first-page":"eadd3867","DOI":"10.1126\/sciadv.add3867","article-title":"Altered host protease determinants for SARS-CoV-2 Omicron","volume":"9","author":"Chan","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mcpro.2025.101314_bib24","doi-asserted-by":"crossref","first-page":"e0085123","DOI":"10.1128\/jvi.00851-23","article-title":"SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models","volume":"97","author":"Mykytyn","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.mcpro.2025.101314_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103255","article-title":"Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity","volume":"65","author":"Hoffmann","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mcpro.2025.101314_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41586-020-2575-3","article-title":"Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2","volume":"585","author":"Hoffmann","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.101314_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021107821","article-title":"TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells","volume":"40","author":"Koch","year":"2021","journal-title":"Embo J."},{"key":"10.1016\/j.mcpro.2025.101314_bib28","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1080\/22221751.2022.2117098","article-title":"Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2","volume":"11","author":"Hu","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.mcpro.2025.101314_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.589505","article-title":"Cathepsin L in COVID-19: from pharmacological evidences to genetics","volume":"10","author":"Gomes","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.mcpro.2025.101314_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107587","article-title":"Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients","volume":"213","author":"Liu","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mcpro.2025.101314_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.mcpro.2025.101314_bib32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s42003-022-03841-8","article-title":"Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture","volume":"5","author":"Yuan","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.mcpro.2025.101314_bib33","doi-asserted-by":"crossref","first-page":"e1009212","DOI":"10.1371\/journal.ppat.1009212","article-title":"Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2","volume":"17","author":"Ou","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mcpro.2025.101314_bib34","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2025.101314_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jsb.2010.09.007","article-title":"Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors","volume":"173","author":"Shenoy","year":"2011","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.mcpro.2025.101314_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/molecules25030698","article-title":"A review of small molecule inhibitors and functional probes of human cathepsin L","volume":"25","author":"Dana","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.mcpro.2025.101314_bib37","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Lysosomotropic agents","volume":"23","author":"De Duve","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mcpro.2025.101314_bib38","article-title":"SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome\/late endosome entry","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.101314_bib39","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1128\/JVI.00415-08","article-title":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide","volume":"82","author":"Bosch","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.mcpro.2025.101314_bib40","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1074\/jbc.M508381200","article-title":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.101314_bib41","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.101314_bib42","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S2213-2600(21)00222-8","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial","volume":"9","author":"Tardif","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.mcpro.2025.101314_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jep.13614","article-title":"Chinese herbal medicine (\u201c3 medicines and 3 formulations\u201d) for COVID-19: rapid systematic review and meta-analysis","volume":"28","author":"Wang","year":"2022","journal-title":"J. Eval. Clin. Pract."}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762500413X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762500413X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T21:11:35Z","timestamp":1766437895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153594762500413X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S153594762500413X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.101314","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Cathepsin L as the Molecular Target of Hydroxychloroquine With Chemical Proteomics","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.101314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101314"}}